In the primary study, use of the most common diabetes medications, metformin and sulfonylureas, was not associated with carriage phenotype while the use of dipeptidyl peptidase 4 (DPP4) inhibitors was, with a higher proportion of intermittent carriers using this drug compared to persistent and noncarriers. The gene discussed is DPP4; the disease is diabetes mellitus.